Background: Drug eluting stents (DES) have been shown to significantly decrease restenosis with subsequent need for lesion and/or vessel revascularization when compared with bare metal stents (BMS) in selected patient groups in randomized trials and in observational registries. If their use in all-comers is also associated with a survival benefit over a longer follow-up is controversial. Methods: We used the Myocardial Infarction Data Acquisition System (MIDAS), a New Jersey statewide database, to examine the mortality of 37,812 patients (pts) who underwent PCI (emergent or elective) with a single stent, either BMS (n=14,939) or DES (n=22,873) from 2003 to 2004, with follow-up of 60 months.
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Background: Previous studies have demonstrated the potential utility of the age, creatinine, and ejection fraction (ACEF) score [age/(left ventricular ejection fraction + 1, if creatinine > 2.0 mg/dL)] to assess the risk of mortality and myocardial infarction (MI) 1 year after percutaneous coronary intervention (PCI). However, this score has not been extensively validated in patients undergoing PCI in routine clinical practice. Therefore, we sought to investigate if the ACEF score would predict adverse events in patients undergoing contemporary PCI. Methods: A total of 2779 patients, who received at least one stent during PCI and of whom data was available to calculate the ACEF score, were selected from Waves 4 (2004) and 5 (2006) of the NHLBI Dynamic Registry. The in-hospital and 3-year outcomes (mortality and MI) were prospectively collected and stratified according to the ACEF score tertiles. Results: The ACEF terciles were as follow: LOW <1.0477, 1.0477≤ MID <1.3819, and HIGH ≥1.3819. An increasing trend in ACEF score was associated with increases in inhospital mortality (LOW = 0%, MID = 0.4%, HIGH = 2%; ptrend <0.0001). Similarly, HIGH had the highest mortality at 3-year follow-up (figure). After adjustment for confounding variables, the relationship between high ACEF score and mortality at 3 years remained statistically significant.
3-year cumulative mortality by ACEF tercile.
Conclusion:
The ACEF score may serve as a risk assessment tool for mortality after PCI. Future studies are needed to better determine the use of ACEF score in routine clinical practice.
